How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Aug 05, 2026, 9:31 PM IST Digitide Solutions - Reg. 34 (1) Annual Report. Aug 05, 2026, 9:17 PM IST Digitide Solutions - Notice Convening The 2Nd Annual General Meeting Aug 03, 2026, 6:07 AM IST ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results